Skip to main content
Erschienen in: Intensive Care Medicine 5/2007

01.05.2007 | Experimental

Infusions of rocuronium and cisatracurium exert different effects on rat diaphragm function

verfasst von: Dries Testelmans, Karen Maes, Patrick Wouters, Scott K. Powers, Marc Decramer, Ghislaine Gayan-Ramirez

Erschienen in: Intensive Care Medicine | Ausgabe 5/2007

Einloggen, um Zugang zu erhalten

Abstract

Objective

Aminosteroidal and benzylisoquinoline neuromuscular blocking agents are used in the intensive care unit to facilitate mechanical ventilation. The use of these agents has been associated with development of critical illness myopathy; however, the relative frequency of myopathy development among agents is not known. The aim of our study was to compare the effects of 24 h infusion of rocuronium or cisatracurium on the diaphragm in mechanically ventilated rats.

Design

Randomized, controlled experiment.

Setting

Basic animal science laboratory.

Subjects

Male Wistar rats, 14 weeks old.

Interventions

Rats were divided into four groups to receive either saline, rocuronium (low dose) or cisatracurium (low or high dose).

Measurements and results

After 24 h, in vitro diaphragm tetanic force was decreased after rocuronium (–33% vs. saline), while the force was more preserved after cisatracurium, even in the high-dose group. Cross-sectional areas of the different diaphragm and gastrocnemius fibers were unaltered. Diaphragmatic MURF-1 mRNA was increased after rocuronium (+44% vs. saline), while unchanged in both cisatracurium groups. Calpain activity was increased after rocuronium (+75% vs. saline) and unchanged in the cisatracurium groups. MURF-1 mRNA expression and calpain activity were negatively correlated with diaphragm force.

Conclusions

Cisatracurium infusion during controlled mechanical ventilation exerted less detrimental effects on diaphragm function and proteolytic activity than infusion of rocuronium, even with the higher effective dose. These data suggest that increased calpain activity and increased activation of the ubiquitin proteasome system play a role in the different effects of these agents.
Literatur
1.
Zurück zum Zitat Murray MJ, Cowen J, DeBlock H, Erstad B, Gray AW Jr, Tescher AN, McGee WT, Prielipp RC, Susla G, Jacobi J, Nasraway SA Jr, Lumb PD (2002) Clinical practice guidelines for sustained neuromuscular blockade in the adult critically ill patient. Crit Care Med 30:142–156CrossRefPubMed Murray MJ, Cowen J, DeBlock H, Erstad B, Gray AW Jr, Tescher AN, McGee WT, Prielipp RC, Susla G, Jacobi J, Nasraway SA Jr, Lumb PD (2002) Clinical practice guidelines for sustained neuromuscular blockade in the adult critically ill patient. Crit Care Med 30:142–156CrossRefPubMed
2.
Zurück zum Zitat Arroliga A, Frutos-Vivar F, Hall J, Esteban A, Apezteguia C, Soto L, Anzueto A (2005) Use of sedatives and neuromuscular blockers in a cohort of patients receiving mechanical ventilation. Chest 128:496–506CrossRefPubMed Arroliga A, Frutos-Vivar F, Hall J, Esteban A, Apezteguia C, Soto L, Anzueto A (2005) Use of sedatives and neuromuscular blockers in a cohort of patients receiving mechanical ventilation. Chest 128:496–506CrossRefPubMed
3.
Zurück zum Zitat Sessler CN (2005) Sedation, analgesia, and neuromuscular blockade for high-frequency oscillatory ventilation. Crit Care Med 33:S209–S216CrossRefPubMed Sessler CN (2005) Sedation, analgesia, and neuromuscular blockade for high-frequency oscillatory ventilation. Crit Care Med 33:S209–S216CrossRefPubMed
4.
Zurück zum Zitat Moore EW, Hunter JM (2001) The new neuromuscular blocking agents: do they offer any advantages? Br J Anaesth 87:912–925CrossRefPubMed Moore EW, Hunter JM (2001) The new neuromuscular blocking agents: do they offer any advantages? Br J Anaesth 87:912–925CrossRefPubMed
5.
Zurück zum Zitat De Jonghe B, Bastuji-Garin S, Sharshar T, Outin H, Brochard L (2004) Does ICU-acquired paresis lengthen weaning from mechanical ventilation? Intensive Care Med 30:1117–1121CrossRefPubMed De Jonghe B, Bastuji-Garin S, Sharshar T, Outin H, Brochard L (2004) Does ICU-acquired paresis lengthen weaning from mechanical ventilation? Intensive Care Med 30:1117–1121CrossRefPubMed
6.
Zurück zum Zitat Olivieri L, Plourde G (2005) Prolonged (more than ten hours) neuromuscular blockade after cardiac surgery: report of two cases. Can J Anaesth 52:88–93CrossRefPubMed Olivieri L, Plourde G (2005) Prolonged (more than ten hours) neuromuscular blockade after cardiac surgery: report of two cases. Can J Anaesth 52:88–93CrossRefPubMed
7.
Zurück zum Zitat Davis NA, Rodgers JE, Gonzalez ER, Fowler AA III (1998) Prolonged weakness after cisatracurium infusion: a case report. Crit Care Med 26:1290–1292CrossRefPubMed Davis NA, Rodgers JE, Gonzalez ER, Fowler AA III (1998) Prolonged weakness after cisatracurium infusion: a case report. Crit Care Med 26:1290–1292CrossRefPubMed
8.
Zurück zum Zitat Tousignant CP, Bevan DR, Eisen AA, Fenwick JC, Tweedale MG (1995) Acute quadriparesis in an asthmatic treated with atracurium. Can J Anaesth 42:224–227CrossRefPubMed Tousignant CP, Bevan DR, Eisen AA, Fenwick JC, Tweedale MG (1995) Acute quadriparesis in an asthmatic treated with atracurium. Can J Anaesth 42:224–227CrossRefPubMed
9.
Zurück zum Zitat Leatherman JW, Fluegel WL, David WS, Davies SF, Iber C (1996) Muscle weakness in mechanically ventilated patients with severe asthma. Am J Respir Crit Care Med 153:1686–1690CrossRefPubMed Leatherman JW, Fluegel WL, David WS, Davies SF, Iber C (1996) Muscle weakness in mechanically ventilated patients with severe asthma. Am J Respir Crit Care Med 153:1686–1690CrossRefPubMed
10.
Zurück zum Zitat Gehr LC, Sessler CN (2001) Neuromuscular blockade in the intensive care unit. Semin Respir Crit Care Med 22:175–188CrossRefPubMed Gehr LC, Sessler CN (2001) Neuromuscular blockade in the intensive care unit. Semin Respir Crit Care Med 22:175–188CrossRefPubMed
11.
Zurück zum Zitat Gayan-Ramirez G, Decramer M (2002) Effects of mechanical ventilation on diaphragm function and biology. Eur Respir J 20:1579–1586CrossRefPubMed Gayan-Ramirez G, Decramer M (2002) Effects of mechanical ventilation on diaphragm function and biology. Eur Respir J 20:1579–1586CrossRefPubMed
12.
Zurück zum Zitat Jaber S, Sebbane M, Koechlin C, Hayot M, Capdevila X, Eledjam JJ, Prefaut C, Ramonatxo M, Matecki S (2005) Effects of short vs. prolonged mechanical ventilation on antioxidant systems in piglet diaphragm. Intensive Care Med 31:1427–1433CrossRefPubMed Jaber S, Sebbane M, Koechlin C, Hayot M, Capdevila X, Eledjam JJ, Prefaut C, Ramonatxo M, Matecki S (2005) Effects of short vs. prolonged mechanical ventilation on antioxidant systems in piglet diaphragm. Intensive Care Med 31:1427–1433CrossRefPubMed
13.
Zurück zum Zitat Testelmans D, Maes K, Wouters P, Gosselin N, Deruisseau K, Powers S, Sciot R, Decramer M, Gayan-Ramirez G (2006) Rocuronium exacerbates mechanical ventilation-induced diaphragm dysfunction in rats. Crit Care Med 34:3018–3023CrossRefPubMed Testelmans D, Maes K, Wouters P, Gosselin N, Deruisseau K, Powers S, Sciot R, Decramer M, Gayan-Ramirez G (2006) Rocuronium exacerbates mechanical ventilation-induced diaphragm dysfunction in rats. Crit Care Med 34:3018–3023CrossRefPubMed
14.
Zurück zum Zitat Laghi F, Tobin MJ (2003) Disorders of the respiratory muscles. Am J Respir Crit Care Med 168:10–48CrossRefPubMed Laghi F, Tobin MJ (2003) Disorders of the respiratory muscles. Am J Respir Crit Care Med 168:10–48CrossRefPubMed
15.
Zurück zum Zitat Testelmans D, Maes K, Wouters P, Decramer M, Gayan-Ramirez G (2006) Different effects of two families of neuromuscular blocking agents on rat diaphragm function during controlled mechanical ventilation. Proc Am Thoracic Soc [Abstract] 3:A137 Testelmans D, Maes K, Wouters P, Decramer M, Gayan-Ramirez G (2006) Different effects of two families of neuromuscular blocking agents on rat diaphragm function during controlled mechanical ventilation. Proc Am Thoracic Soc [Abstract] 3:A137
16.
Zurück zum Zitat Gayan-Ramirez G, De Paepe K, Cadot P, Decramer M (2003) Detrimental effects of short-term mechanical ventilation on diaphragm function and IGF-I mRNA in rats. Intensive Care Med 29:825–833CrossRefPubMed Gayan-Ramirez G, De Paepe K, Cadot P, Decramer M (2003) Detrimental effects of short-term mechanical ventilation on diaphragm function and IGF-I mRNA in rats. Intensive Care Med 29:825–833CrossRefPubMed
17.
Zurück zum Zitat Dekhuijzen PN, Gayan-Ramirez G, de Bock V, Dom R, Decramer M (1993) Triamcinolone and prednisolone affect contractile properties and histopathology of rat diaphragm differently. J Clin Invest 92:1534–1542CrossRefPubMedPubMedCentral Dekhuijzen PN, Gayan-Ramirez G, de Bock V, Dom R, Decramer M (1993) Triamcinolone and prednisolone affect contractile properties and histopathology of rat diaphragm differently. J Clin Invest 92:1534–1542CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Takamure M, Murata KY, Tamada Y, Azuma M, Ueno S (2005) Calpain-dependent alpha-fodrin cleavage at the sarcolemma in muscle diseases.Muscle Nerve 32:303–309CrossRefPubMed Takamure M, Murata KY, Tamada Y, Azuma M, Ueno S (2005) Calpain-dependent alpha-fodrin cleavage at the sarcolemma in muscle diseases.Muscle Nerve 32:303–309CrossRefPubMed
19.
Zurück zum Zitat Kent MP, Veiseth E, Therkildsen M, Koohmaraie M (2005) An assessment of extraction and assay techniques for quantification of calpain and calpastatin from small tissue samples. J Anim Sci 83:2182–2188CrossRefPubMed Kent MP, Veiseth E, Therkildsen M, Koohmaraie M (2005) An assessment of extraction and assay techniques for quantification of calpain and calpastatin from small tissue samples. J Anim Sci 83:2182–2188CrossRefPubMed
20.
Zurück zum Zitat Czogalla A, Sikorski AF (2005) Spectrin and calpain: a `target' and a `sniper' in the pathology of neuronal cells. Cell Mol Life Sci 62:1913–1924CrossRefPubMed Czogalla A, Sikorski AF (2005) Spectrin and calpain: a `target' and a `sniper' in the pathology of neuronal cells. Cell Mol Life Sci 62:1913–1924CrossRefPubMed
22.
Zurück zum Zitat Whetstone Foster JG, Clark AP (2006) Functional recovery after neuromuscular blockade in mechanically ventilated critically ill patients. Heart Lung 35:178–189CrossRefPubMed Whetstone Foster JG, Clark AP (2006) Functional recovery after neuromuscular blockade in mechanically ventilated critically ill patients. Heart Lung 35:178–189CrossRefPubMed
23.
Zurück zum Zitat Prielipp RC, Coursin DB, Wood KE, Murray MJ (1995) Complications associated with sedative and neuromuscular blocking drugs in critically ill patients. Crit Care Clin 11:983–1003PubMed Prielipp RC, Coursin DB, Wood KE, Murray MJ (1995) Complications associated with sedative and neuromuscular blocking drugs in critically ill patients. Crit Care Clin 11:983–1003PubMed
24.
Zurück zum Zitat De Jonghe B, Sharshar T, Lefaucheur JP, Authier FJ, Durand-Zaleski I, Boussarsar M, Cerf C, Renaud E, Mesrati F, Carlet J, Raphael JC, Outin H Bastuji-Garin S (2002) Paresis acquired in the intensive care unit: a prospective multicenter study. JAMA 288:2859–2867CrossRefPubMed De Jonghe B, Sharshar T, Lefaucheur JP, Authier FJ, Durand-Zaleski I, Boussarsar M, Cerf C, Renaud E, Mesrati F, Carlet J, Raphael JC, Outin H Bastuji-Garin S (2002) Paresis acquired in the intensive care unit: a prospective multicenter study. JAMA 288:2859–2867CrossRefPubMed
25.
Zurück zum Zitat Filatov GN, Rich MM (2004) Hyperpolarized shifts in the voltage dependence of fast inactivation of Nav1.4 and Nav1.5 in a rat model of critical illness myopathy. J Physiol 559:813–820CrossRefPubMedPubMedCentral Filatov GN, Rich MM (2004) Hyperpolarized shifts in the voltage dependence of fast inactivation of Nav1.4 and Nav1.5 in a rat model of critical illness myopathy. J Physiol 559:813–820CrossRefPubMedPubMedCentral
26.
Zurück zum Zitat Murray MJ, Brull SJ, Bolton CF (2006) Brief review: Nondepolarizing neuromuscular blocking drugs and critical illness myopathy. Can J Anaesth 53:1148–1156CrossRefPubMed Murray MJ, Brull SJ, Bolton CF (2006) Brief review: Nondepolarizing neuromuscular blocking drugs and critical illness myopathy. Can J Anaesth 53:1148–1156CrossRefPubMed
27.
Zurück zum Zitat Gutmann L, Blumenthal D, Gutmann L, Schochet SS (1996) Acute type II myofiber atrophy in critical illness. Neurology 46:819–821CrossRefPubMed Gutmann L, Blumenthal D, Gutmann L, Schochet SS (1996) Acute type II myofiber atrophy in critical illness. Neurology 46:819–821CrossRefPubMed
28.
Zurück zum Zitat Gayan-Ramirez G, Testelmans D, Maes K, Racz GZ, Cadot P, Zador E, Wuytack F, Decramer M (2005) Intermittent spontaneous breathing protects the rat diaphragm from mechanical ventilation effects. Crit Care Med 33:2804–2809CrossRefPubMed Gayan-Ramirez G, Testelmans D, Maes K, Racz GZ, Cadot P, Zador E, Wuytack F, Decramer M (2005) Intermittent spontaneous breathing protects the rat diaphragm from mechanical ventilation effects. Crit Care Med 33:2804–2809CrossRefPubMed
29.
Zurück zum Zitat DeRuisseau KC, Shanely RA, Akunuri N, Hamilton MT, Van Gammeren D, Zergeroglu AM, McKenzie M, Powers SK (2005) Diaphragm unloading via controlled mechanical ventilation alters the gene expression profile. Am J Respir Crit Care Med 172:1267–1275CrossRefPubMedPubMedCentral DeRuisseau KC, Shanely RA, Akunuri N, Hamilton MT, Van Gammeren D, Zergeroglu AM, McKenzie M, Powers SK (2005) Diaphragm unloading via controlled mechanical ventilation alters the gene expression profile. Am J Respir Crit Care Med 172:1267–1275CrossRefPubMedPubMedCentral
30.
Zurück zum Zitat Shanely RA, Zergeroglu MA, Lennon SL, Sugiura T, Yimlamai T, Enns D, Belcastro A, Powers SK (2002) Mechanical ventilation-induced diaphragmatic atrophy is associated with oxidative injury and increased proteolytic activity. Am J Respir Crit Care Med 166:1369–1374CrossRefPubMed Shanely RA, Zergeroglu MA, Lennon SL, Sugiura T, Yimlamai T, Enns D, Belcastro A, Powers SK (2002) Mechanical ventilation-induced diaphragmatic atrophy is associated with oxidative injury and increased proteolytic activity. Am J Respir Crit Care Med 166:1369–1374CrossRefPubMed
31.
Zurück zum Zitat DeRuisseau KC, Kavazis AN, Deering MA, Falk DJ, Van Gammeren D, Yimlamai T, Ordway GA, Powers SK (2005) Mechanical ventilation induces alterations of the ubiquitin–proteasome pathway in the diaphragm. J Appl Physiol 98:1314–1321CrossRefPubMed DeRuisseau KC, Kavazis AN, Deering MA, Falk DJ, Van Gammeren D, Yimlamai T, Ordway GA, Powers SK (2005) Mechanical ventilation induces alterations of the ubiquitin–proteasome pathway in the diaphragm. J Appl Physiol 98:1314–1321CrossRefPubMed
32.
Zurück zum Zitat Jackman RW, Kandarian SC (2004) The molecular basis of skeletal muscle atrophy. Am J Physiol Cell Physiol 287:C834–C843CrossRefPubMed Jackman RW, Kandarian SC (2004) The molecular basis of skeletal muscle atrophy. Am J Physiol Cell Physiol 287:C834–C843CrossRefPubMed
33.
Zurück zum Zitat Di Giovanni S, Molon A, Broccolini A, Melcon G, Mirabella M, Hoffman EP, Servidei S (2004) Constitutive activation of MAPK cascade in acute quadriplegic myopathy. Ann Neurol 55:195–206CrossRefPubMed Di Giovanni S, Molon A, Broccolini A, Melcon G, Mirabella M, Hoffman EP, Servidei S (2004) Constitutive activation of MAPK cascade in acute quadriplegic myopathy. Ann Neurol 55:195–206CrossRefPubMed
34.
Zurück zum Zitat Latronico N, Peli E, Botteri M (2005) Critical illness myopathy and neuropathy. Curr Opin Crit Care 11:126–132CrossRefPubMed Latronico N, Peli E, Botteri M (2005) Critical illness myopathy and neuropathy. Curr Opin Crit Care 11:126–132CrossRefPubMed
35.
Zurück zum Zitat Attaix D, Ventadour S, Codran A, Bechet D, Taillandier D, Combaret L (2005) The ubiquitin–proteasome system and skeletal muscle wasting. Essays Biochem 41:173–186CrossRefPubMed Attaix D, Ventadour S, Codran A, Bechet D, Taillandier D, Combaret L (2005) The ubiquitin–proteasome system and skeletal muscle wasting. Essays Biochem 41:173–186CrossRefPubMed
36.
Zurück zum Zitat Kandarian SC, Jackman RW (2006) Intracellular signaling during skeletal muscle atrophy. Muscle Nerve 33:155–165CrossRefPubMed Kandarian SC, Jackman RW (2006) Intracellular signaling during skeletal muscle atrophy. Muscle Nerve 33:155–165CrossRefPubMed
37.
Zurück zum Zitat Cai D, Frantz JD, Tawa NE Jr, Melendez PA, Oh BC, Lidov HG, Hasselgren PO, Frontera WR, Lee J, Glass DJ, Shoelson SE (2004) IKKbeta/NF-kappaB activation causes severe muscle wasting in mice. Cell 119:285–298CrossRefPubMed Cai D, Frantz JD, Tawa NE Jr, Melendez PA, Oh BC, Lidov HG, Hasselgren PO, Frontera WR, Lee J, Glass DJ, Shoelson SE (2004) IKKbeta/NF-kappaB activation causes severe muscle wasting in mice. Cell 119:285–298CrossRefPubMed
38.
Zurück zum Zitat Fareed MU, Evenson AR, Wei W, Menconi M, Poylin V, Petkova V, Pignol B, Hasselgren PO (2006) Treatment of rats with calpain inhibitors prevents sepsis-induced muscle proteolysis independent of atrogin-1/MAFbx and MuRF1 expression. Am J Physiol Regul Integr Comp Physiol 290:R1589–R1597CrossRefPubMed Fareed MU, Evenson AR, Wei W, Menconi M, Poylin V, Petkova V, Pignol B, Hasselgren PO (2006) Treatment of rats with calpain inhibitors prevents sepsis-induced muscle proteolysis independent of atrogin-1/MAFbx and MuRF1 expression. Am J Physiol Regul Integr Comp Physiol 290:R1589–R1597CrossRefPubMed
39.
Zurück zum Zitat McDonald MC, Mota-Filipe H, Paul A, Cuzzocrea S, Abdelrahman M, Harwood S, Plevin R, Chatterjee PK, Yaqoob MM, Thiemermann C (2001) Calpain inhibitor I reduces the activation of nuclear factor-kappaB and organ injury/dysfunction in hemorrhagic shock. FASEB J 15:171–186CrossRefPubMed McDonald MC, Mota-Filipe H, Paul A, Cuzzocrea S, Abdelrahman M, Harwood S, Plevin R, Chatterjee PK, Yaqoob MM, Thiemermann C (2001) Calpain inhibitor I reduces the activation of nuclear factor-kappaB and organ injury/dysfunction in hemorrhagic shock. FASEB J 15:171–186CrossRefPubMed
40.
Zurück zum Zitat Goll DE, Thompson VF, Li H, Wei W, Cong J (2003) The calpain system. Physiol Rev 83:731–801CrossRefPubMed Goll DE, Thompson VF, Li H, Wei W, Cong J (2003) The calpain system. Physiol Rev 83:731–801CrossRefPubMed
41.
Zurück zum Zitat Machida K, Ishibashi R, Hara T, Ohtsuka A, Hayashi K (2003) Effects of corticosterone on Ca2+ uptake and myofibrillar disassembly in primary muscle cell culture. Biosci Biotechnol Biochem 67:244–249CrossRefPubMed Machida K, Ishibashi R, Hara T, Ohtsuka A, Hayashi K (2003) Effects of corticosterone on Ca2+ uptake and myofibrillar disassembly in primary muscle cell culture. Biosci Biotechnol Biochem 67:244–249CrossRefPubMed
Metadaten
Titel
Infusions of rocuronium and cisatracurium exert different effects on rat diaphragm function
verfasst von
Dries Testelmans
Karen Maes
Patrick Wouters
Scott K. Powers
Marc Decramer
Ghislaine Gayan-Ramirez
Publikationsdatum
01.05.2007
Verlag
Springer Berlin Heidelberg
Erschienen in
Intensive Care Medicine / Ausgabe 5/2007
Print ISSN: 0342-4642
Elektronische ISSN: 1432-1238
DOI
https://doi.org/10.1007/s00134-007-0584-4

Weitere Artikel der Ausgabe 5/2007

Intensive Care Medicine 5/2007 Zur Ausgabe

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.